Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAsset Writedowns and ImpairmentCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashChange in IntangiblesChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesOther financing activitiesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Biomerica (BMRA) Other financing activities (2021 - 2025)

Biomerica's Other financing activities history spans 4 years, with the latest figure at -$126000.0 for Q4 2025.

  • For Q4 2025, Other financing activities changed N/A year-over-year to -$126000.0; the TTM value through Nov 2025 reached $15000.0, changed N/A, while the annual FY2025 figure was $44000.0, 45.68% down from the prior year.
  • Other financing activities for Q4 2025 was -$126000.0 at Biomerica, down from $133000.0 in the prior quarter.
  • Across five years, Other financing activities topped out at $652000.0 in Q2 2023 and bottomed at -$126000.0 in Q4 2025.
  • The 4-year median for Other financing activities is $23476.0 (2021), against an average of $67083.3.
  • The largest YoY upside for Other financing activities was 152951.64% in 2023 against a maximum downside of 94.27% in 2023.
  • A 4-year view of Other financing activities shows it stood at $29486.0 in 2021, then plummeted by 83.04% to $5000.0 in 2022, then skyrocketed by 12940.0% to $652000.0 in 2023, then plummeted by 119.33% to -$126000.0 in 2025.
  • Per Business Quant, the three most recent readings for BMRA's Other financing activities are -$126000.0 (Q4 2025), $133000.0 (Q3 2025), and -$84000.0 (Q2 2025).